| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-96 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-96 |
| filingDate |
2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112341429-B |
| titleOfInvention |
An intermediate compound of an immunomodulator |
| abstract |
The present invention relates to an intermediate compound of an IL-17A modulator compound. The IL-17A modulator compound synthesized by the intermediate compound of the present invention has good IL-17A inhibitory activity. |
| priorityDate |
2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |